"Our board certified hematologists and oncologists employ the most advanced protocols in fighting cancer. Chemotherapy is administered by a nursing staff with specialized training in oncology. Our infusion center is uniquely designed to provide comfort and privacy including patient rooms with television, a movie library, recliners, and are staffed with expert intravenous clinical registered nurses and patient care technicians."

During the past decade, Sparrow Regional Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 97 clinical trials were completed, i.e. on average, 1616.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 13 clinical trials were completed. i.e. 1300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sparrow Regional Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 70 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Radiation Therapy Oncology Group" with 16 trials sponsored, "Eastern Cooperative Oncology Group" with 14 trials sponsored and "NSABP Foundation Inc" with 14 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sparrow Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Sparrow Regional Cancer Center" are "Breast Cancer" (38 trials), "Lung Cancer" (28 trials), "Prostate Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials) and "Lymphoma" (12 trials). Many other conditions were trialed in "Sparrow Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Sparrow Regional Cancer Center" are "Drug" (134 trials), "Other" (52 trials), "Biological" (40 trials), "Radiation" (31 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (30 trials), "carboplatin" (18 trials), "bevacizumab" (15 trials), "radiation therapy" (15 trials) and "cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Sparrow Regional Cancer Center" are 137 trials for "All" genders, 27 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Sparrow Regional Cancer Center". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 144 completed trials in Sparrow Regional Cancer Center, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Sparrow Regional Cancer Center, 5 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".